Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder.
Agrawal M, Emanuel E, Richards B, Richards W, Roddy K, Thambi P
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (0)
No references identified in the available metadata. This does not establish that none exist.
Cited by — these papers cite this paper (11)
- Caution before canonisation: a clinical and implementation science perspective on psychedelics 2026-10-05 · Expand citations
- Study participant perceptions of the relevance of therapist and study team personal psychedelic experience 2026-10-03 · Expand citations
- Learnings from a hybrid communities of practice group therapy model to support psilocybin-assisted therapy for patients with a terminal diagnosis 2026-07-20 · Expand citations
- Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overview 2026-07-13 · Expand citations
- Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New Mexico 2026-06-17 · Expand citations
- Sex-specific increased reactivity of the PVT and prolonged PVT→CeA circuit engagement following psilocin administration 2026-04-10 · Expand citations
- Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications 2026-04-01 · Expand citations
- Low-income group psilocybin assisted therapy for depression: An Oregon feasibility study 2026-02-12 · Expand citations
- Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 Study 2026-01-18 · Expand citations
- Five-year outcomes of psilocybin-assisted therapy for Major Depressive Disorder 2025-09-04 · Expand citations
- Group Format Psilocybin-Assisted Therapy: Commentary on the HOPE trial (HOPE: a pilot study of psilocybin-enhanced group psychotherapy in patients with cancer) 2022-10-03 · Expand citations